Talactoferrin

DRUG5 trials

Sponsors

Agennix, National Cancer Institute (NCI), Stanford University

Conditions

Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaNon Small Cell Lung CancerNon-Small Cell Lung CancerNosocomial InfectionsRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx

Phase 1

Study of Talactoferrin Oral Solution for Nosocomial Infection in Preterm Infants

AgennixNosocomial Infections

Start: 2009-06-30End: 2012-12-31Target: 120Updated: 2012-03-15

Effect of Talactoferrin in Adults With Non-Small Cell Lung Cancer

CompletedNCT00923741

National Cancer Institute (NCI)Non-Small Cell Lung Cancer

Start: 2008-06-19End: 2010-02-01Updated: 2018-07-05

Talactoferrin in Treating Patients With Relapsed or Refractory Non-Small Cell Lung Cancer or Squamous Cell Head and Neck Cancer

TerminatedNCT01528137

Stanford UniversityMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer +43

Start: 2012-05-31End: 2013-07-31Updated: 2016-08-02

Phase 3

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer

AgennixNon Small Cell Lung Cancer

Start: 2009-02-28End: 2016-03-31Target: 1100Updated: 2012-03-15

Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung Cancer

CompletedNCT00707304

AgennixNon Small Cell Lung Cancer

Start: 2008-11-30End: 2012-08-31Updated: 2012-08-21

Related Papers

Randomized Control Trial of Human Recombinant Lactoferrin: A Substudy Reveals Effects on the Fecal Microbiome of Very Low Birth Weight Infants.

2016-06-0134 citations

Randomized Controlled Trial of Talactoferrin Oral Solution in Preterm Infants.

2016-05-3137 citations